Post-immunochemotherapy radiotherapy Is unnecessary in some diffuse large B-cell lymphoma cases

Adjuvant radiotherapy for diffuse large B-cell lymphoma is unnecessary for elderly patients who have positron emission tomography (PET)-negative bulky disease following immunochemotherapy, according to an interim analysis of the phase III OPTIMAL>60 clinical trial presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Cancer Network